Stereotactic body radiation therapy for thoracic cancers: Recommendations for patient selection, setup and therapy

Frontiers of Radiation Therapy and Oncology

Volumn 43, Issue , 2011, Pages 395-411

  Timmerman, Robert ^a   Heinzerling, John ^a   Abdulrahman, Ramzi ^a   Choy, Hak ^a   Meyer, John L ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b Saint Francis Memorial Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ARTICLE; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; CONE BEAM COMPUTED TOMOGRAPHY; DOSIMETRY; GAMMA KNIFE RADIOSURGERY; HUMAN; LUNG CANCER; LUNG LOBECTOMY; MEASUREMENT ERROR; MOTION; OUTCOME ASSESSMENT; PATIENT SELECTION; PHASE 1 CLINICAL TRIAL (TOPIC); PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIATION SAFETY; RESIDUAL VOLUME; STEREOTACTIC BODY RADIATION THERAPY; THORAX CANCER; TREATMENT OUTCOME; TREATMENT PLANNING; VACUUM;

CLINICAL TRIALS AS TOPIC; HUMANS; PATIENT SELECTION; RADIOSURGERY; THORACIC NEOPLASMS;

APPLICATION PROGRAMS; BIOLOGICAL ORGANS; DISEASES;

ADVANCED TECHNOLOGY; CLINICAL PRACTICES; CLINICAL PROCEDURE; LONG-TERM EVALUATION; MEDICALLY INOPERABLE; STEREOTACTIC BODY RADIATION THERAPY; TECHNICAL EXPERTISE; THERAPEUTIC OUTCOMES;

RADIOTHERAPY;

EID: 79958231739     PISSN: 00719676     EISSN: 16623789     Source Type: Book Series    
DOI: 10.1159/000322503     Document Type: Article

References (24)

1. Lo SS, Fakiris AJ, Chang EL, et al: Stereotactic body radiation therapy: a novel treatment modality. Nat Rev Clin Oncol 2009; 7: 44-54.
2. Timmerman R, Abdulrahman R, Kavanagh BD, Meyer JL: Lung cancer: a model for implementing stereotactic body radiation therapy into practice. Front Radiat Ther Oncol 2007; 40: 368-385.
3. Timmerman RD, Park C, Kavanagh BD: The North American experience with stereotactic body radiation therapy in non-small cell lung cancer. J Thorac Oncol 2007; 2:S101-S112. (Pubitemid 47183603)
4. Blomgren H, Lax I, Naslund I, Svanstrom R: Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol 1995; 34: 861-870.
5. Uematsu M, Shioda A, Tahara K, et al: Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients: a preliminary experience. Cancer 1998; 82: 1062-1070. (Pubitemid 28136518)
6. Timmerman R, Paulus R, Galvin J, et al: RTOG 0236: stereotactic body radiation therapy (SBRT) to treat medically inoperable early stage lung cancer patients. American Society for Therapeutic Radiology and Oncology (ASTRO) Annual Meeting; 2009 November 2, 2009; Chicago, IL.
7. Int J Radiat Oncol Biol Phys 2009;75(suppl):S3.
8. Perez CA, Bauer M, Edelstein S, Gillespie BW, Birch R: Impact of tumor control on survival in carcinoma of the lung treated with irradiation. Int J Radiat Oncol Biol Phys 1986; 12: 539-547. (Pubitemid 16081614)
9. Perez CA, Bauer M, Emami BN, et al: Thoracic irradiation with or without levamisole (NSC #177023) in unresectable non-small cell carcinoma of the lung: a phase III randomized trial of the RTOG. Int J Radiat Oncol Biol Phys 1988; 15: 1337-1346. (Pubitemid 19015475)
10. Timmerman R, Papiez L, McGarry R, et al: Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I nonsmall cell lung cancer. Chest 2003; 124: 1946-1955. (Pubitemid 37433596)
11. Schefter TE, Kavanagh BD, Timmerman RD, Cardenes HR, Baron A, Gaspar LE: A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. Int J Radiat Oncol Biol Phys 2005; 62: 1371-1378. (Pubitemid 40982057)
12. Xiao Y, Papiez L, Paulus R, et al: Dosimetric evaluation of heterogeneity corrections for RTOG 0236: stereotactic body radiotherapy of inoperable stage I-II non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2009; 73: 1235-1242.
13. Timmerman R, Galvin J, Michalski J, et al: Accreditation and quality assurance for Radiation Therapy Oncology Group: multicenter clinical trials using stereotactic body radiation therapy in lung cancer. Acta Oncol 2006; 45: 779-786. (Pubitemid 44423122)
14. Timmerman R, McGarry R, Yiannoutsos C, et al: Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 2006; 24: 4833-4839. (Pubitemid 46630909)
15. McGarry RC, Papiez L, Williams M, Whitford T, Timmerman RD: Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study. Int J Radiat Oncol Biol Phys 2005; 63: 1010-1015. (Pubitemid 41505277)
16. Ginsberg RJ, Rubinstein LV: Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 1995; 60: 615-622, discussion 22-23.
17. Onishi H, Araki T, Shirato H, et al: Stereotactic hypofractionated high-dose irradiation for stage I non-small cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multi-institutional study. Cancer 2004; 101: 1623-1631. (Pubitemid 39318910)
18. M. D. Anderson Cancer Center to lead study of surgery vs. CyberKnife Radiosurgery for operable lung cancer patients. http://www.accuray. com/PressReleases.aspx?release=676 (October 26, 2007).
19. Hurkmans CW, Cuijpers JP, Lagerwaard FJ, et al: Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study. Radiat Oncol 2009; 4: 1.
20. Yaes RJ, Kalend A: Local stem cell depletion model for radiation myelitis. Int J Radiat Oncol Biol Phys 1988; 14: 1247-1259.
21. Wolbarst AB, Chin LM, Svensson GK: Optimization of radiation therapy: integral-response of a model biological system. Int J Radiat Oncol Biol Phys 1982; 8: 1761-1769. (Pubitemid 13236241)
22. Wolbarst AB: Optimization of radiation therapy II: the critical-voxel model. Int J Radiat Oncol Biol Phys 1984; 10: 741-745. (Pubitemid 14084227)
23. Timmerman RD: An overview of hypofractionation and introduction to this issue of seminars in radiation oncology. Semin Radiat Oncol 2008; 18: 215-222.
24. Mayer R, Williams A, Frankel T, et al: Two-dimensional film dosimetry application in heterogeneous materials exposed to megavoltage photon beams. Med Phys 1997; 24: 455-460. (Pubitemid 27133491)